This compound is a salt form of the rosuvastatin intermediate, specifically the tert-butylamine salt of (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-isopropylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid. It is used as a key pharmaceutical intermediate in the manufacturing of rosuvastatin calcium.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 917805-74-4
Rosuvastatin
active pharmaceutical ingredient
Tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
Rosuvastatin calcium intermediate
2-Chloro-3-methyl-4-(trifluoromethyl)pyridine
Pharmaceutical intermediate for synthesis
Methyl 5-amino-4-fluoro-1-methyl-1H-benzimidazole-6-carboxylate
pharmaceutical intermediate
1-Propanesulfonamide, N-[3-[(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-
Pharmaceutical intermediate
4-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde
Pharmaceutical intermediate for kinase inhibitors
Rosuvastatin diastereomers
pharmaceutical impurity reference standard
Sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate
active pharmaceutical ingredient
(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;2-methylpropan-2-amine
OBQRUQWCSRLLAM-DHMAKVBVSA-N
CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)(C)N
—